| 注册
首页|期刊导航|Hepatobiliary & Pancreatic Diseases International|Hepatocellular carcinoma and liver transplant:What about neo-and adjuvant immunotherapy

Hepatocellular carcinoma and liver transplant:What about neo-and adjuvant immunotherapy

Mohamed H Khalaf Benjamin Tran Felix Krendl Tina Doan John Rachko Rebecca Marino Parissa Tabrizian

Hepatobiliary & Pancreatic Diseases International2026,Vol.25Issue(3):P.270-279,10.
✕
Hepatobiliary & Pancreatic Diseases International2026,Vol.25Issue(3):P.270-279,10.DOI:10.1016/j.hbpd.2025.10.004

Hepatocellular carcinoma and liver transplant:What about neo-and adjuvant immunotherapy

Mohamed H Khalaf 1Benjamin Tran 1Felix Krendl 1Tina Doan 1John Rachko 1Rebecca Marino 1Parissa Tabrizian1

作者信息

  • 1. Liver Transplant and Hepatobiliary Surgery,Recanati/Miller Transplantation Institute,Icahn School of Medicine at Mount Sinai,New York 10029,NY,USA
  • 折叠

摘要

关键词

Hepatocellular carcinoma/Liver transplantation/Immune checkpoint inhibitor/Neoadjuvant/Adjuvant/Downstaging/Immunotherapy

分类

医药卫生

引用本文复制引用

Mohamed H Khalaf,Benjamin Tran,Felix Krendl,Tina Doan,John Rachko,Rebecca Marino,Parissa Tabrizian..Hepatocellular carcinoma and liver transplant:What about neo-and adjuvant immunotherapy[J].Hepatobiliary & Pancreatic Diseases International,2026,25(3):P.270-279,10.

Hepatobiliary & Pancreatic Diseases International

1499-3872

访问量0
|
下载量0
段落导航相关论文